$APOG

Apogee raises fiscal 2027 guidance after second-quarter sales rise

Apogee Enterprises (APOG) reported a 9.2% sales increase to $391.1M in Q2, raising its fiscal 2027 adjusted EPS guidance to $3.00-$3.40 and net sales outlook to $1.46B-$1.50B. Operating income rose 24.5% to $33.5M, while net earnings fell 5.4% to $22.4M. Growth was driven by acquisitions, pricing, and product mix, though offset by lower volume and higher costs.

Original reporting
Published Oct 6, 2026, 4:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 4:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Apogee raises fiscal 2027 guidance after second-quarter sales rise — source image
Decision brief

The 30-second read

$APOGBullishHigh
01

Why it matters

The guidance raise is a primary corporate disclosure that can move the stock sharply, as evidenced by an 18% intraday gain.

02

Market read

Guidance lift is likely to drive further buying pressure in the near term.

03

What to watch

Potential headwinds from rising material and manufacturing costs could offset sales growth.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Apogee Enterprises, a provider of architectural building products, reported Q2 results with net sales of $391.1 million and raised FY2027 guidance.

Company-level read

Ticker impact

$APOGBullishHigh confidence
Context

Apogee raised FY2027 adjusted EPS guidance to $3.00‑$3.40 and sales outlook to $1.46B‑$1.50B after Q2 net sales rose 9.2%.

Expected impact

likely upward pressure as investors price in higher earnings and sales expectations

Evidence & confidence

Guidance increase is material and fresh; shares already up 18% intraday, indicating market reaction.

Market effects

Improves outlook for architectural building products sector as Apogee's growth may lift peers.

Positive for U.S. industrial and construction‑related equities.

Limited to U.S. market; no direct global macro effect.

Counterpoint

If higher costs persist, the guidance may be overly optimistic and could be revised down later.

Key entities

  • Apogee Enterprises

    NASDAQ‑listed architectural building products firm.

Related articles

$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

$APOGHighAI 8/10

Apogee (APOG) Q2 2027 Earnings Call Transcript

Apogee (APOG) reported Q2 2027 earnings with net sales up 9.2% to $391.1M, driven by acquisitions and pricing. Adjusted EBITDA margin rose to 12.7%, and EPS increased 19% to $1.17. The company highlighted progress in metals, services, and glass segments, with services delivering 10 consecutive quarters of growth. Acquisitions of Kalwall and GrowGlass are expected to enhance capabilities and profitability. Management expressed confidence in long-term growth and shareholder value creation.

$APOGMedAI 8/10

Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance

Apogee Enterprises (APOG) reported Q2 2027 revenue of $391M, up 9% YoY, and adjusted EPS of $1.17, up 19%. The company raised its fiscal 2027 outlook due to strong first-half performance. Segment performance varied, with Services growing for the 10th consecutive quarter, while Glass and Performance Surfaces faced challenges. Acquisitions of Kalwall and Groglass are progressing well. Leverage ratio is 1.7 times, slightly above target. The company repurchased $6.4M of stock in Q2.

$APOGMed

Apogee Enterprises Q2 Earnings Call Highlights

Apogee Enterprises reported Q2 sales growth in all segments, with Architectural Metals up 1.8%, Services up 8%, Glass up 21%, and Performance Surfaces up 14%. Adjusted EBITDA margins varied, with Glass improving sequentially. The company expects Kalwall and Groglass acquisitions to boost revenue but have a modest EPS impact in 2027. Apogee repurchased $6.4M in stock and paid $5.5M in dividends, maintaining a leverage ratio of 1.7x.

$CEGHighAI 8/10

Market movers: Constellation Energy, Marvell, Lamb Weston, Option Care

Diodes (DIOD) received a buy rating and $135 target from BofA, expecting 58% annual EPS growth. Apogee (APOG) raised fiscal 2027 guidance after Q2 sales rose 9.2%. Marvell (MRVL) shares rose 6.5% on $70B-$90B 2031 revenue forecast. Lamb Weston (LW) increased 2027 targets despite net income drop. SAP (SAP) to acquire TechWolf; Mckesson (MCK) & CD&R to buy Option Care Health (OPCH) for $5.8B. Constellation Energy (CEG) in 20-year PPA with Alphabet (GOOG).